A.A. van Vliet

413 total citations
13 papers, 320 citations indexed

About

A.A. van Vliet is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, A.A. van Vliet has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in A.A. van Vliet's work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (4 papers) and Hepatitis B Virus Studies (2 papers). A.A. van Vliet is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Hepatitis C virus research (4 papers) and Hepatitis B Virus Studies (2 papers). A.A. van Vliet collaborates with scholars based in Netherlands, United States and France. A.A. van Vliet's co-authors include Renger G. Tiessen, David L. Cutler, Robert B. Keller, Teddy Kosoglou, Larisa Reyderman, Jochem R. van Werven, Aart J. Nederveen, Jaap Stoker, Johannes M. Hoogduin and Erik S.G. Stroes and has published in prestigious journals such as Hepatology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

A.A. van Vliet

13 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.A. van Vliet Netherlands	9	144	107	72	51	49	13	320
Jessica P.E. Davis United States	10	143 1.0×	157 1.5×	19 0.3×	31 0.6×	73 1.5×	28	273
Feliciano Chanana Paquissi Angola	7	121 0.8×	63 0.6×	39 0.5×	80 1.6×	55 1.1×	9	299
Holly Cline-Fedewa United States	10	104 0.7×	128 1.2×	9 0.1×	47 0.9×	42 0.9×	16	334
Tae Hun Kim South Korea	11	128 0.9×	75 0.7×	37 0.5×	40 0.8×	44 0.9×	28	296
K. Patsiaoura Greece	11	135 0.9×	108 1.0×	10 0.1×	24 0.5×	131 2.7×	21	358
César Yaghi Lebanon	10	131 0.9×	67 0.6×	25 0.3×	33 0.6×	79 1.6×	41	346
Theresa H. Wirtz Germany	11	120 0.8×	71 0.7×	41 0.6×	90 1.8×	54 1.1×	41	352
Tariq Roshan Canada	11	80 0.6×	40 0.4×	54 0.8×	5 0.1×	16 0.3×	29	365
Hidemi Dodo Japan	10	106 0.7×	11 0.1×	113 1.6×	28 0.5×	71 1.4×	16	403
Paul S. Monroe United States	9	144 1.0×	122 1.1×	13 0.2×	41 0.8×	123 2.5×	16	377

Countries citing papers authored by A.A. van Vliet

Since Specialization

Citations

This map shows the geographic impact of A.A. van Vliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.A. van Vliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.A. van Vliet more than expected).

Fields of papers citing papers by A.A. van Vliet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.A. van Vliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.A. van Vliet. The network helps show where A.A. van Vliet may publish in the future.

Co-authorship network of co-authors of A.A. van Vliet

This figure shows the co-authorship network connecting the top 25 collaborators of A.A. van Vliet. A scholar is included among the top collaborators of A.A. van Vliet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.A. van Vliet. A.A. van Vliet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Vliet, A.A. van, C.D. Forbes, Jurriaan B. Tuynman, et al.. (2024). Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions. Clinical & Experimental Immunology. 216(2). 159–171. 4 indexed citations

Tiessen, Renger G., Ciara Kennedy, Bradley T. Keller, et al.. (2018). Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. BMC Gastroenterology. 18(1). 3–3. 45 indexed citations

Jansen, Henk, A.T.M. Aerts, A.A. van Vliet, et al.. (2015). Total energy expenditure assessed by salivary doubly labelled water analysis and its relevance for short‐term energy balance in humans. Rapid Communications in Mass Spectrometry. 30(1). 143–150. 3 indexed citations

Bruijne, Joep de, Jeroen van de Wetering de Rooij, A.A. van Vliet, et al.. (2012). First-in-Human Study of the Pharmacokinetics and Antiviral Activity of IDX375, a Novel Nonnucleoside Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 56(8). 4525–4528. 8 indexed citations

Kosoglou, Teddy, Larisa Reyderman, Renger G. Tiessen, et al.. (2011). Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects. European Journal of Clinical Pharmacology. 68(3). 249–258. 76 indexed citations

Bergmann, Jean‐François, Joep de Bruijne, Robert J. de Knegt, et al.. (2011). Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV. Alimentary Pharmacology & Therapeutics. 34(4). 443–453. 43 indexed citations

Boonstra, André, Bisheng Liu, Zwier M. A. Groothuismink, et al.. (2011). Potent Immune Activation in Chronic Hepatitis C Patients upon Administration of An Oral Inducer of Endogenous Interferons that Acts via Toll-Like Receptor 7. Antiviral Therapy. 17(4). 657–667. 25 indexed citations

Bruijne, Joep de, Jean‐François Bergmann, H. W. Reesink, et al.. (2010). Antiviral Activity of Narlaprevir Combined with Ritonavir and Pegylated Interferon in Chronic Hepatitis C Patients. Hepatology. 52(5). 1590–1599. 24 indexed citations

Werven, Jochem R. van, Johannes M. Hoogduin, Aart J. Nederveen, et al.. (2009). Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. Journal of Magnetic Resonance Imaging. 30(2). 444–448. 60 indexed citations

10.

Tiessen, Renger G., et al.. (2008). Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects. International Journal of Clinical Pharmacology and Therapeutics. 46(9). 443–452. 11 indexed citations

11.

Legangneux, Eric, et al.. (2003). Lack of effect of amisulpride on the pharmacokinetics and safety of lithium. The International Journal of Neuropsychopharmacology. 6(2). 103–109. 9 indexed citations

12.

Vliet, A.A. van, W. H. L. Hackeng, A. J. M. Donker, & S.G.M. Meuwissen. (1992). Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis. Journal of Hepatology. 15(1-2). 40–47. 8 indexed citations

13.

Vliet, A.A. van & A. Th. M. van Balen. (1985). Kératopathie dans la maladie de Crohn. Ophthalmologica. 190(2). 72–76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact